Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study

Peer Review reports

Original Submission
14 Mar 2023	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
Resubmission - Version 4
	Submitted	Manuscript version 4
23 Dec 2023	Reviewed	Reviewer Report
2 Jan 2024	Reviewed	Reviewer Report - Marlies Michl
15 Mar 2024	Author responded	Author comments - Elena Elez
Resubmission - Version 5
15 Mar 2024	Submitted	Manuscript version 5
Publishing
20 Mar 2024	Editorially accepted
11 Apr 2024	Article published	10.1186/s12885-024-12153-5

Back to article page